Ripple Science’s Post

🚀 Zulfiya Garyaeva is in #Tbilisi for the Georgia Medtech Summit 2024!🚀 She is already on the ground at the Georgia Medtech Summit in, connecting with key innovators and thought leaders! A special thanks to Clinical Accelerator and Nikolai "Nik" Nikitin, MD, PhD for organizing this exciting event. Don't miss the opportunity to catch up with Zulfiya and dive into the latest advancements in medical technology! #MedTech #GeorgiaSummit #Innovation #1MED #GeorgiaMedtechSummit #HealthcareInnovation #MedTech #Networking #1MED

🌟 Earning Your Stars & Stripes – The US Playbook I had the privilege to attend this insightful panel at the LSX Nordic Congress, focusing on scaling healthtech and medtech companies in the US market. A huge thank you to Paula Petcu for introducing me to this event and facilitating my access. Your support made this experience possible! Key takeaways from the panel: -> Philip Siberg warned that entering the US market may cost ten times your initial budget and advised being cautious with sales strategies. -> Martin Bostrup, PhD highlighted that having solid evidence from the EU can significantly expedite market entry in the US. I look forward to collaborating further with him on creating strong evidence in medical affairs. -> @Filip Peters emphasized the importance of building strong connections with the FDA and exploring NIH programs for funding. -> Jørn Emborg reminded us that networking is crucial for success in the US market, stating, “It’s not always about money; it’s about having the right connections.” -> Shilpa Ashok Razdan stressed starting with feasibility studies to build robust data packages for the US. At Erudita.tech, we’re dedicated to streamlining processes in decision-making and regulatory documentation. Our solutions can empower your organization to navigate the complexities of the US market more effectively, expediting systematic reviews and enhancing compliance. If these challenges resonate with your organization, let’s connect! hashtag #LSXNordic #HealthTech #MedTech #USMarket #RegulatoryCompliance #AI #Erudita #Collaboration #DecisionMaking

As technology drives breakthroughs in clinical research, it's also transforming how clinical trials are managed. Clay Williams with Greenphire shares how their platform GreenSpace is simplifying clinical trial participation. From submitting receipts to tracking reimbursements, hear how GreenSpace removes barriers for both participants and sites ⇢ https://lnkd.in/g8PiNDXN

Today is #InternationalClinicalTrialsDay! As Sponsor of innovative clinical trials, GCAR is dedicated to the advancement of science by modernizing clinical trials to accelerate the time from discovery in the lab to use in the clinic resulting in better treatments and lives saved. To learn more about our research, visit: gcaresearch.org #clinicalresearch #clinicaltrials #masterprotocol #platformtrial

@CRIO partnered with TOTAL Diversity Clinical Trial Management because we believe that technology should be a part of the solution when it comes to increasing diversity in clinical trials. It would not have happened if it was not for uMotif, Alcanza Clinical Research and Worldwide Clinical Trials! If you don't have time to read the entire thing, at the very least, check out Appendix A for real-world advice on how technology can increase diversity in clinical trials! #clinicaltrials #innovationtechnology #diversity

Despite the slowdown in deal-making in 2023, opportunities are on the up as Tier 1 companies increasingly outsource innovation. What is the outlook of top strategics as they form partnerships in 2024? At #MedtechLeaders this April as part of our LSX World Congress 2024, our medtech executive speakers will explore the transformative potential of collaborative alliances, focusing on key topics such as: 🔹 Navigating regulatory challenges through partnerships with Tier 1 manufacturers 🔹 Addressing privacy and data management in collaborative ventures 🔹 Harnessing academic research to achieve market success in partnerships Meet Our Expert Panelists: 🎤 Stuart Hart, MD, MBA, MS, FACOG, FACS, Chief Scientific Officer, Integra LifeSciences 🎤 Ori Hadomi, VP Strategic Initiatives & Partnerships, Medtronic 🎤 Jan Kimpen, Former CMO Philips, Partner, Sanara 🎤 Kathleen Van Vlierberghe, VP Healthcare Solutions & Partnerships EMEA, Boston Scientific Scheduled as our opening keynote 09.10 April 29th, this panel will be kicking off a jam-packed two days of content, partnering, workshops and showcases. Registrations are still open for this event, visit here - https://lnkd.in/esbJsTJ9 - to learn more and secure your spot at our earlybird rates. #medtech #medicaldevices #medicaldevice #lsxwc24 #ml24 #innovation #investing #showcase #lifesciences

Delighted to announce the successful organization and execution of our recent seminar, 'For the Love of Innovation'. This event brought together industry experts and thought leaders to explore cutting-edge advancements in pharmacogenetics and Next Generation Sequencing technologies, featuring Thermo Fisher's innovative solutions. The seminar facilitated a dynamic exchange of ideas, fostering collaboration and knowledge sharing among attendees. Key takeaways included the transformative potential of these technologies in revolutionizing healthcare and precision medicine. Our team looks forward to continuing the conversation on shaping the future of healthcare. Walid ESSID Thermo Fisher Scientific HA SHAH #Innovation #Pharmacogenetics #NextGenerationSequencing #ThermoFisher #Seminar #Collaboration #Healthcare #PrecisionMedicine"

Join us at #THS2024 for an insightful forum from RFB Stiftung für Pathobiochemie und Molekulare Diagnostik - Referenzinstitut für Bioanalytik where experts will dive deep into key healthcare topic ( Quality in Medical Laboratory and it’s impact on healthcare ), driving innovation and fostering collaboration for a healthier future. Don’t miss this engaging session! #ths2024 #tuelekeezanzibaroktoba

After #AusMedtech2024, what's next for our sector? The Australian medical technology ecosystem is flourishing, covering nearly 600 companies and boasting the highest rate of growth in life sciences according to AusBiotech research. But that doesn't mean the work is over – one of the major takeaways from AusMedtech 2024 is that the medtech innovation system is disconnected and fragmented. A national approach to medtech that pools resources and speaks in a single voice to government is a top priority, helping connect people and facilities to enable innovation across the sector. As a voice to industry, the VMH has a role to play in this too, collaborating with our colleagues at AusBiotech, the Medical Technology Association of Australia (MTAA), ANDHealth, The Australian National Fabrication Facility (ANFF), the Medical Device Partnering Program, and BioMelbourne Network to help unify the sector. We already have the infrastructure, skills, technical expertise, and training resources necessary to accelerate medtech in Australia, it's just about getting it into the right hands. The VMH is helping to bridge this gap through our Navigator initiative, connecting government, academia, and businesses to better make use of our state’s amazing medtech capabilities. Learn more about the work we're doing to support our medtech sector: https://lnkd.in/gEDXBtRF

Breaking news: We've hit a major milestone at bioaccess®! First Patients Treated with Sparta Biomedical Ormi Device This isn't just a win for us. It's a leap forward for: • Patients awaiting innovative treatments • MedTech companies eyeing LATAM expansion • The entire Latin American healthcare ecosystem Key takeaway: Latin America is ready for cutting-edge clinical research. Are you considering LATAM for your next trial? Let's connect. Your next breakthrough might be closer than you think. #ClinicalTrials #LatAmMedTech #bioaccess